Initial study to assess the effects of topical XXXX for @entity158 after haemorrhoidectomy.

@entity1 @entity1242 @entity158 @entity10 @entity282
BACKGROUND: @entity282 remains the most dreaded part of haemorrhoidectomy in the minds of both @entity1 and doctors. It may delay @entity1 discharge, recovery, and return to work. @entity1242 has been used successfully in the treatment of anal fissures. We investigated its topical use in the management of @entity158 after haemorrhoidectomy. METHOD: Twenty @entity1 were entered into a double-blind trial and randomised into two groups. Group A (n = 10) applied @entity1242 ointment (0.2% twice daily) to the perianal area following surgery, and Group B applied a placebo ointment. They applied the ointment for up to 42 days after surgery, or until they felt it necessary to stop the treatment. @entity1 scored their daily anal @entity158 using a visual analogue scale. Six weeks after surgery, @entity1 were reviewed by an independent observer. RESULTS: The total @entity158 score was calculated for each @entity1 . The median score for Group A was 50.65; the median score for Group B was 73.50. There was no significant difference in @entity158 scores between both groups, even when aberrant results were ignored. 20% of @entity1 in each group complained that the ointment caused @entity10 . CONCLUSION: The results suggest that topical @entity1242 ointment may not significantly reduce @entity282 following haemorrhoidectomy. Meta-analysis would provide a more definitive answer.
